文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症监护中的肠道完整性:宿主通透性改变与微生物组作为潜在治疗靶点

Gut integrity in intensive care: alterations in host permeability and the microbiome as potential therapeutic targets.
PubMed 文献 · J Intensive Care · 2025-03-18
一句话结论重症患者常见肠道通透性增加和微生物组紊乱,可能驱动全身炎症和器官功能障碍,调控肠道通透性和恢复微生物组组成有望成为重症治疗新策略。

该综述探讨了肠道完整性在重症疾病中的作用。肠道由约40万亿微生物、单层肠上皮细胞和黏膜免疫系统组成,正常情况下紧密连接选择性转运必需分子并防止病原体易位。重症疾病破坏肠道屏障功能,导致肠道通透性增加、上皮细胞凋亡和免疫激活,微生物组向以病原微生物为主的「病理微生物组」转变,加剧全身炎症和器官功能障碍。恢复肠道完整性的潜在治疗靶点包括调节上皮细胞功能、调节紧密连接蛋白和抑制上皮细胞凋亡;微生物组靶向治疗如益生元、益生菌、粪菌移植和选择性消化道去污染已被广泛研究,但未来仍需验证其临床疗效及个体化靶向的可能性。

要点

  • 重症患者肠道通透性增加和微生物组紊乱常见,可能驱动全身炎症失调和器官功能障碍。
  • 肠道屏障由单层肠上皮细胞及紧密连接构成,重症时紧密连接破坏导致病原体易位。
  • 微生物组向「病理微生物组」转变,病原微生物毒力因子表达增加,加剧全身炎症。
  • 潜在治疗靶点包括调节上皮细胞功能、调节紧密连接蛋白、抑制上皮细胞凋亡。
  • 微生物组靶向治疗(益生元、益生菌、粪菌移植、选择性消化道去污染)已被广泛研究,但疗效仍需临床验证。

适用人群与场景

  • 重症患者(危重症人群),适用于ICU场景。

处置流程与药物剂量

  • 潜在治疗靶点包括调节上皮细胞功能、调节紧密连接蛋白和抑制上皮细胞凋亡。
  • 微生物组靶向治疗包括益生元、益生菌、粪菌移植和选择性消化道去污染,已被广泛研究以促进重症患者肠道稳态恢复。

研究设计与关键结果

  • 综述指出重症疾病破坏肠道屏障功能,导致肠道通透性增加、上皮细胞凋亡和免疫激活,微生物组向「病理微生物组」转变,加剧全身炎症和器官功能障碍。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:未来研究需要验证这些干预措施在临床环境中的潜在疗效,并确定是否可以对肠道进行个体化靶向治疗。

对床旁实践的改变

  • 作者认为,调节肠道通透性和恢复微生物组组成的治疗策略有望成为重症患者的新疗法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The gut has long been hypothesized to be the "motor" of critical illness, propagating inflammation and playing a key role in multiple organ dysfunction. However, the exact mechanisms through which impaired gut integrity potentially contribute to worsened clinical outcome remain to be elucidated. Critical elements of gut dysregulation including intestinal hyperpermeability and a perturbed microbiome are now recognized as potential therapeutic targets in critical care.

MAIN BODY: The gut is a finely tuned ecosystem comprising ~ 40 trillion microorganisms, a single cell layer intestinal epithelia that separates the host from the microbiome and its products, and the mucosal immune system that actively communicates in a bidirectional manner. Under basal conditions, these elements cooperate to maintain a finely balanced homeostasis benefitting both the host and its internal microbial community. Tight junctions between adjacent epithelial cells selectively transport essential molecules while preventing translocation of pathogens. However, critical illness disrupts gut barrier function leading to increased gut permeability, epithelial apoptosis, and immune activation. This disruption is further exacerbated by a shift in the microbiome toward a "pathobiome" dominated by pathogenic microbes with increased expression of virulence factors, which intensifies systemic inflammation and accelerates organ dysfunction. Research has highlighted several potential therapeutic targets to restore gut integrity in the host, including the regulation of epithelial cell function, modulation of tight junction proteins, and inhibition of epithelial apoptosis. Additionally, microbiome-targeted therapies, such as prebiotics, probiotics, fecal microbiota transplantation, and selective decontamination of the digestive tract have also been extensively investigated to promote restoration of gut homeostasis in critically ill patients. Future research is needed to validate the potential efficacy of these interventions in clinical settings and to determine if the gut can be targeted in an individualized fashion.

CONCLUSION: Increased gut permeability and a disrupted microbiome are common in critical illness, potentially driving dysregulated systemic inflammation and organ dysfunction. Therapeutic strategies to modulate gut permeability and restore the composition of microbiome hold promise as novel treatments for critically ill patients.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Oami T, Shimazui T, Yumoto T, et al. Gut integrity in intensive care: alterations in host permeability and the microbiome as potential therapeutic targets. J Intensive Care. 2025. PMID: 40098052. doi:10.1186/s40560-025-00786-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。